Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Eli Lilly and Company
These methods can achieve bioavailability approaching injection levels while avoiding needle phobia concerns
Bonifcio, V
1 Introduction Viral vectors are modified viruses that deliver therapeutic genetic material to target cells and are an emerging platform for gene therapy ( A prototype strain of coxsackievirus A21 (CVA21), a non-enveloped enterovirus in the Picornaviridae family, is undergoing clinical evaluation as an oncolytic virus immunotherapy application for the treatment of several types of cancers ( Based on reports that enteroviruses interact with intracellular antioxidant glutathione (GSH) during capsid assembly in infected cells ( The objective of this work was to establish a robust and scalable purification method of CVA21 with high infectivity yield and purity that can accommodate variable cell culture conditions
A randomized trial by Longland et al
US$ 28.77
US$ 28.33
US$ 22.87
US$ 28.84
